Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01029444 · ClinicalTrials.gov registry record · Phase 3
Effects of Pulsed Intravenous (IV) Insulin on Brittle and Uncontrolled Diabetes
A Phase 3 study, sponsored by Florida Atlantic University.
- Terminated
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
NCT01029444: Clinical Trial Phase 3 study, sponsored by Florida Atlantic University.
NCT01029444 is a Phase 3 study that was terminated before completion, run by Florida Atlantic University. The registered enrollment target is 300 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01029444, a Phase 3 study, was terminated before completion, sponsored by Florida Atlantic University.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if restoring normal metabolic function in patients with either type I or type II diabetes can improve the impact of the consequences of diabetic complications specifically on the wide swings in blood glucoses with erratic control even under optimal conditions. Patients are treated once a week with pulsatile intravenous insulin therapy mimicking normal insulin secretion. Blood sugar diaries and laboratory tests including quarterly Hemoglobin A1c levels are monitored to measure progress and outcomes.
Interventions
- PROCEDURE Pulsatile Intravenous Insulin Therapy (Humulin, Humulog, Novolog )
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2007-03 |
| Est. Completion | 2012-03 |
| Phase | Phase 3 |
Why NCT01029444 stopped before completion
NCT01029444 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (61% lower).
The record links to 0 conditions, and to 1 intervention - of which Pulsatile Intravenous Insulin Therapy (Humulin, Humulog, Novolog ) is the first listed.
NCT01029444 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01029444 about?
NCT01029444 is a clinical study titled "Effects of Pulsed Intravenous (IV) Insulin on Brittle and Uncontrolled Diabetes". The purpose of this study is to determine if restoring normal metabolic function in patients with either type I or type II diabetes can improve the impact of the consequences of diabetic complications specifically on the wide swings in blood glucoses with erratic control even under optimal condition...
What is the current status of trial NCT01029444?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2007-03. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01029444?
The interventions under investigation include: Pulsatile Intravenous Insulin Therapy (Humulin, Humulog, Novolog ) (PROCEDURE).
Who is sponsoring clinical trial NCT01029444?
This trial is sponsored by Florida Atlantic University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01029444's enrollment target sits among peer trials
300 1122nd of 2000 higher than 840 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia